Literature DB >> 11089660

Reintroduction of influenza A to a nursing building.

P J Drinka1, S Gravenstein, P Krause, L Nest, M Dissing, P Shult.   

Abstract

We report an outbreak of influenza A from a four-building veterans' facility in King, Wisconsin. Influenza was isolated in 154 of 721 residents over a 121-day period. Building A had 2 cases, no isolates for 40 days, followed by 27 cases. Building B had 25 cases, no isolates for 75 days, followed by 4 cases. Building C had 23 cases, no isolates for 14 days, followed by 17 cases. Influenza A may be reintroduced to a nursing building. Surveillance with contingency plans for restarting of prophylaxis must continue for the duration of influenza in the community.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11089660     DOI: 10.1086/501715

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  4 in total

1.  Computational fluid dynamics study on the influence of an alternate ventilation configuration on the possible flow path of infectious cough aerosols in a mock airborne infection isolation room.

Authors:  Deepthi Sharan Thatiparti; Urmila Ghia; Kenneth R Mead
Journal:  Sci Technol Built Environ       Date:  2016-09-19       Impact factor: 1.990

2.  Assessing Effectiveness of Ceiling-Ventilated Mock Airborne Infection Isolation Room in Preventing Hospital-Acquired Influenza Transmission to Health Care Workers.

Authors:  Deepthi Sharan Thatiparti; Urmila Ghia; Kenneth R Mead
Journal:  ASHRAE Trans       Date:  2016

Review 3.  Indoor air quality and human health: truth vs mass hysteria.

Authors:  Christopher Chang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2004-12       Impact factor: 8.667

Review 4.  Influenza outbreak control practices and the effectiveness of interventions in long-term care facilities: a systematic review.

Authors:  Kaitlin Rainwater-Lovett; Kevin Chun; Justin Lessler
Journal:  Influenza Other Respir Viruses       Date:  2013-11-07       Impact factor: 4.380

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.